as mentioned in
About CVS Health CorporationCVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company.
Wealth Enhancement Advisory Services LLC acquired a new stake in CVS Health Corporation (NYSE:CVS) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Pinkerton Retirement Specialists LLC boosted its stake in CVS Health Corporation by 3,475.0% in the second quarter.
Finally, Integrated Wealth Management boosted its stake in CVS Health Corporation by 3.8% in the third quarter.
MCF Advisors LLC boosted its stake in CVS Health Corporation by 20.0% in the second quarter.
CVS – Buy The Dip Pre-Earnings – CVS Health Corporation (NYSE:CVS)
Buy CVS Health Corporation (NYSE:CVS) on the dip and before earnings on the 7th.
Pressures:The three biggest players in the PBM marketplace are CVS Health, ExpressScripts (NASDAQ:ESRX), and United Health (NYSE:UNH).
But that just isn’t the case, Express Scripts is valued at 15.76 P/E vs. CVS Health being valued at 16.03.
Express Scripts is the only pure play on the PBM market out of the three listed above.
This valuation may be explained away by shorts by saying that the increased competition in the retail market is depressing the stock price.
CVS Health Corporation Company ProfileCVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company.
COPYRIGHT VIOLATION NOTICE: “Atlantic Securities Lowers CVS Health Corporation (CVS) to Neutral” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem.
Receive News & Stock Ratings for CVS Health Corporation Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.
CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $106.67.
CVS Health Corporation (NYSE:CVS) was downgraded by stock analysts at Atlantic Securities from an “overweight” rating to a “neutral” rating in a research note issued on Monday.
collected by :Molly Tony